A 50-year-old woman presented with a 3-day history of a progressive, painful, non-blanchable, purpuric rash (retiform purpura) with areas of necrosis and bullae formation involving her face, trunk, extremities, and oral and nasal mucosa ( Figure 1 ). She endorsed a history of cocaine use, and urine toxicology screening was positive for both cocaine and levamisole by liquid chromatography-tandem mass spectrometry. Laboratory findings included leukopenia and an elevated erythrocyte sedimentation rate (67 mm/h). Antinuclear antibody and antineutrophil cytoplasmic antibody (ANCA) testing was positive with elevated antimyeloperoxidase and antiproteinase 3. An anticardiolipin antibody assay was negative.
She was diagnosed with levamisole-induced vasculitis given the typical features of diffuse purpuric lesions (including the helical rims of the ears) and associated ANCA positivity in the appropriate epidemiologic context 1,2 . Intravenous dexamethasone (4 mg/day for 7 days) was initiated, which halted progression of skin lesions. She was transferred to a burn unit where she received surgical debridement of the necrotic tissue and skin grafting.
Levamisole, a common diluent used in the preparation of powder and crack cocaine, is thought to augment cocaine's pleasurable "high" 3 . Levamisole is an immune modulator and anthelmintic agent that was removed from several national markets because of toxicities such as vasculitis and leukopenia 3, 4 .
Optimal treatments for this condition remain to be elucidated, but drug cessation, supportive care, steroids, plasmapheresis, and surgical debridement are described 3, 4, 5 . Use of cocaine adulterated with levamisole has markedly increased in the past few years and levamisole-induced vasculitis 
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